Multiplesclerosisnewstoday iconMultiplesclerosisnewstodaySep 3, 2026

€1.1M grant moves novel skin patch for MS closer to first human trial

Researchers in Germany have been granted more than $1 million to support the development of a novel skin patch designed to promote myelin repair in people with multiple sclerosis (MS) — funding that brings the experimental treatment closer to clinical testing, according to the team. The patch contains theophylline, a drug long used to treat […]

€1.1M grant moves novel skin patch for MS closer to first human trial
Read original More from Multiplesclerosisnewstoday

Share this story

Send the public story page.

Useful takeaways from this story.

Researchers in Germany have been granted more than $1 million to support the development of a novel skin patch designed to promote myelin repair in people with multiple sclerosis (MS) — funding that brings...

The patch contains theophylline, a drug long used to treat […]

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

Researchers in Germany have been granted more than $1 million to support the development of a novel skin patch designed to promote myelin repair in people with multiple sclerosis (MS) — funding that brings the experimental treatment closer to clinical testing, according to the team. The patch contains theophylline, a drug long used to treat […]

How it works

  • Researchers in Germany have been granted more than $1 million to support the development of a novel skin patch designed to promote myelin repair in people with multiple sclerosis (MS) — funding that brings...

Example or evidence

  • The patch contains theophylline, a drug long used to treat […]

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app